Cathepsin B in gingival crevicular fluid of adult periodontitis patients: Identification by immunological and enzymological methods

Inflammation Research

Volumn 45, Issue 6, 1996, Pages 277-282

  Ichimaru, E ^a,b   Tanoue, M ^a   Tani, M ^a   Tani, Y ^a   Kaneko, T ^a   Iwasaki, Y ^a   Kunimatsu, K ^a   Kato, I ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin B; Cysteine proteinase; Gingival crevicular fluid; Periodontitis

Indexed keywords

CATHEPSIN B; CYSTATIN; CYSTEINE PROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; GINGIVITIS; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MALE; PATHOGENESIS; PERIODONTITIS;

BLOTTING, WESTERN; CATHEPSIN B; CYSTATINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROMETRY; GINGIVAL CREVICULAR FLUID; HUMANS; HYDROLYSIS; IMMUNOENZYME TECHNIQUES; MOLECULAR WEIGHT; PERIODONTITIS; SUBSTRATE SPECIFICITY; ULTRAFILTRATION;

EID: 0029887074     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02280991     Document Type: Article

References (30)

1. Barrett AJ, Kirschke H. Cathepsin B, cathepsin H and cathepsin L. Meth Enzymol 1981;80:535-61.
2. Katunuma N, Kakegawa H, Matsunaga Y, Nikawa I, Kominami E. Different functional share of individual lysosomal cathepsins in normal and pathological conditions. In: Cheronis JC, Repine JE, editors. Proteases, protease inhibitors and protease-derived peptides. Basel: Birkhäuser, 1993:195-210.
3. Guinec N, Dalet-Fumeron V, Pagano M. In vitro study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin and release of gelatinase activities from basement membrane fibronectin. Biol Chem Hoppe-Seyler 1993;374: 1135-46.
4. Maciewicz RA, Wotton SF, Etherington DJ, Duannce VC. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsin B and L. FEBS Lett 1990;269:189-93.
5. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tunour tissues. Biochem J 1992; 282:273-8.
6. Eeckhout Y, Delaisse JM, Ledent P, Vaes G. The proteinases of bone resorption. In: Glauert AM, editor. The control of tissue damage. Amsterdam: Elsevier Science Publishers B.V. 1988:297-313.
7. Etherrington DJ, Maciewicz RA, Taylor MAJ, Wardale RJ. The role of collagen-degrading cysteine proteinases in connective tissue metabolism. In: Turk V, editor. Cysteine proteinases and their inhibitors. Berlin: Walter de Gruyter 1986;269-82.
8. Sloane BF, Lah TT, Day NA, Rozhin J, Bando Y, Honn KV. Tumor cysteine proteinases and their inhibitors. In: Turk V, editor. Cysteine proteinases and their inhibitors. Berlin: Walter de Gruyter 1986;729-49.
9. Meheus LA, Fransen LM, Raymakers JG, Blockx HA, Van Beeumen JJ, Van Bun SM, et al. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol 1993;151:1535-47.
10. Katunuma N. Participation of lysosomal cathepsins in antigen processing and bone resorption. In: Katunuma N, Suzuki K, Travis J, Fritz J, editors. Biological functions of proteinases and inhibitors. Tokyo: Japan Scientific Societies Press 1994:3-21.
11. Jochum, M, Machleidt W, Fritz H. Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches. In: Cheronis JC, Repine JE, editors. Protease, protease inhibitors and Protease-Derived peptides. Agents Actions Suppl. Vol. 42. Basel: Birkhäuser 1993:51-69.
12. Meijers MHM, KoopdonK-Kool J, Meacock SCR, VanNoorden CJF, Bunning RAD, Billingham MEJ. Cysteine proteinase activity in the development of arthritis in an adjuvant model of the rat. Agents Actions 1993;39:C219-21.
13. Huet G, Flipo RM, Richet C, Thiebaut C, Demeyer D, Balduyck M, et al. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis. Clin Chem 1992;38:1694-7.
14. Kennett CN, Cox, SW, Eley BM. Comparative histochemical, biochemical and immunocytochemical studies of cathepsin B in human gingiva. J Periodont Res 1994;29:203-13.
15. Eley BM, Cox SW. Cathepsin B- and L-Like activities at local gingival sites of chronic periodontitis patients. J Clin Periodontol 1991;18:499-504.
16. Eley BM, Cox SW. Cathepsin B/L, elastase-, tryptase-trypsin-and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: correlation with clinical parameters in untreated chronic periodontitis patients. J Periodont Res 1992;27:62-9.
17. Cox SW, Eley BM. Detection of cathepsin B- and L-, elastase-, tryptase-, trypsin-, and dipeptidyl peptidase-like activities in crevicular fluid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4 trifluoromethyl coumarin. J Periodont Res 1989;24:353-61.
18. Kunimatsu K, Yamamoto K, Ichimaru E, Kato Y, Kato I. Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J Periodont Res 1990;25:69-73.
19. Kadowaki T, Yoneda M, Okamoto K, Maeda K, Yamamoto K. Purification and characterization of a noval arginine-specific cysteine proteinase (argingipain) involved in the pathogenesis of periodontal disease from the culture supernatant of Porphyromonas gingivalis. J Biol Chem 1994;269:21371-8.
20. Bedi SG, Williams T. Purification and characterization of a collagen-degrading protease from Porphyromonas gingivalis. J Biol Chem 1994;269:599-606.
21. Chen Z, Potempa J, Polanowski A, Wikstrom M, Travis J. Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem 1992;267:18896-901.
22. Ichimaru E, Imura K, Hara Y, Kato Y, Kato I. Cystatin activity in gingival crevicular fluid from periodontal disease patents measured by a now quantitative analysis method. J Periodont Res 1992;27:119-125.
23. Hizawa K, Nonaka I, Sugita H, Kominami E, Katunuma N. Abnormal increase of lysosomal cysteine proteinases in rimmed vacuoles in the skeletal muscle. Am J Pathol 1986;122:193-8.
24. Ichimaru E, Sakai H, Saku T, Kunimatsu K, Kato Y, Kato I, et al. Characterization of hemoglobin-hydrolyzing acidic proteinases in human and rat neutrophils. J Biochem 1990; 108:1009-15.
25. Udenfriend S, Stein S, Bohlen P, Dairman W. Fluorescamine: A reagent for assay of amino acid, peptides, proteins, and primary amines in the picomole range. Science 1972;178:871-2.
26. Barrett AJ. Cystatin, the egg white inhibitor of cysteine proteinases. Meth Enzymol 1981;80:711-78.
27. Barrett AJ, Rawling ND, Davies ME, Machleidt W, Salvesen G, Turk V. Cysteine proteinase inhibitors of the cystatin superfamily. In: Barrett AJ, Salvesen G, editors. Proteinase inhibitors. Amsterdam: Elsevier, 1986:515-69.
28. Towatari T, Nikawa T, Murata M, Yokoo C, Tamai M, Hanada K, et al. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo. FEBS Lett 1991;280:311-5.
29. Kominami E, Kutunuma N. Biosynthesis, processings and localizations of lysosomal cysteine proteinases. In: Katunuma N, Kominami E, editors. Intracellular Proteolysis. Tokyo: Japan Scientific Societies Press 1989:52-60.
30. Cimasoni G. Crevicular Fluid Updated. In: Myers HM, editor. Monographs in Oral Sciences. Basel: Karger 1983:1-152.